NCT04935021招募中4 期
Clinical Study Protocol of Transthyroxine Protein Amyloidosis Cardiomyopathy and Its Gene Carriers
Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年6月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Rate of cardiovascular death, myocardial infarction, and stroke
研究概览
简要总结
In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients and gene carriers of ATTR-CM confirmed in the Second Affiliated Hospital of Zhejiang University School of Medicine, regardless of gender, age 18-90 years old;
- •Patients who have the ability to understand the test and can cooperate with investigators
排除标准
- •Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors
研究组 & 干预措施
ATTR-CM
Experimental
Patients or Gene carrier
干预措施: ATTR-CM (Drug)
结局指标
主要结局
Rate of cardiovascular death, myocardial infarction, and stroke
时间窗: 10 year
Primary Outcome
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown EtiologyTransthyretin Amyloidosis Cardiomyopathy (ATTR-CM)NCT03842163Pfizer812
招募中
不适用
Thailand ATTR-CM RegistryTransthyretin Amyloid Cardiomyopathy (ATTR-CM)NCT06338696Mahidol University105
已完成
2 期
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid CancerThyroid CancerNCT00181168Johns Hopkins University63
招募中
不适用
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on TafamidisAmyloidosis CardiacATTR Amyloidosis Wild TypeAmyloidosisNCT06251778Paolo Milani200
已完成
不适用
Cost-effectiveness of TPMT PharmacogeneticsInflammatory Bowel DiseasesUlcerative ColitisCrohn DiseaseNCT00521950ZonMw: The Netherlands Organisation for Health Research and Development853